BioIdeations
BioIdeations is a Gurgaon-based private investment firm that funds 30-60% of late-stage clinical development costs for life sciences companies at Phase II/III/IV, offering regulatory mentoring and emerging-market access across multiple geographies.
- Company typePrivate
- Founded-
- HeadquartersGurugram, India
- Headcount1–10
- GTM typeB2B
- OfferingServices
What BioIdeations does
BioIdeations is a privately held, Gurgaon-based investment firm that deploys patient capital into clinical-stage life sciences companies, funding 30-60% of the capital required for late-stage (Phase II, III, or IV) clinical development. Its target portfolio spans Pharmaceuticals, BioPharmaceuticals, Medical Devices, Botanicals, Nutraceuticals, and Cosmeceuticals, with stated particular interest in Orphan Drugs and 505(b)(2) candidates. The firm positions itself not as a passive financier but as an active co-development partner, providing mentoring on complex business and regulatory issues alongside its investment.
The firm's core differentiator is human expertise and network rather than technology: a team with over a century of cumulative experience in drug development and regulatory affairs, combined with a cultivated global network of life-sciences professionals across the US, Europe, Middle East, India, and South East Asia. Its operating geographies extend further to include market-access support in South America, South East Asia, Middle-East, and Far-East for portfolio companies seeking commercialization pathways. No proprietary technology platform, software product, or AI/ML capability is disclosed — the offering is fundamentally a relationship-driven investment and advisory service.
The business model centers on equity investment returns realized through portfolio company exits (strategic sales, IPOs, or other liquidity events), with the firm explicitly seeking management teams that present a clear exit strategy proposal. Deal sourcing is direct and relationship-driven: initial email inquiry with executive summary and investor presentation, followed by techno-commercial evaluation, phone/video conference, in-person meeting, and due diligence. Marketing is minimal — a website and a single contact email — consistent with a small (1-10 employees), high-touch investment operation. No fund size, AUM, portfolio company names, revenue, or transaction history are disclosed, which limits external verification of scale or track record.
BioIdeations firmographics
Firmographics- Name
- BioIdeations
- Legal name
- BioIdeations
- Website
- https://bioideations.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioIdeations is a Gurgaon-based private investment firm that funds 30-60% of late-stage clinical development costs for life sciences companies at Phase II/III/IV, offering regulatory mentoring and emerging-market access across multiple geographies.
- Ownership category
- akta.pro rank
BioIdeations industry classification
Industry- Product category
- Life Sciences Investment
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Biosimilar Development & Clinical/Regulatory Services (comparability, trials, pharmacovigilance) (HLAAAHAJ)
- akta.pro secondary industry
- Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
Keywords
Where BioIdeations is headquartered
LocationHeadquarters
- HQ city
- Gurugram
- HQ country
- India
- HQ region
- Asia
Markets served
BioIdeations business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Investment Returns: BioIdeations generates returns through equity investments in life sciences companies, providing 30-60% of funding required for late-stage clinical development. Returns are realized through portfolio company exits, typically via strategic sales, IPOs, or other liquidity events as part of their exit strategy partnerships with management teams.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
BioIdeations product offering
Product offeringCore offering
BioIdeations is a life sciences investment firm that provides equity capital covering 30-60% of late-stage clinical development costs for life sciences companies at Phase II, III, or IV of clinical development, or ready to commercialize. The firm focuses on Pharmaceuticals, BioPharmaceuticals, Medical Devices, Botanicals, Nutraceuticals, and Cosmeceuticals, with particular interest in Orphan Drugs and 505(b)(2) candidates. In addition to capital, BioIdeations provides mentoring on regulatory and business issues, clinical/regulatory strategy development, and market-access support across India, South America, South East Asia, Middle-East, and Far-East.
Product overview
BioIdeations is a life sciences investment firm, not a technology product company. The company provides investment capital and strategic advisory services to life sciences companies, including Pharmaceuticals, BioPharmaceuticals, Medical Devices, Botanicals, Nutraceuticals, and Cosmeceuticals companies. Their core offering is investment funding (covering 30-60% of late-stage clinical development costs), combined with mentoring on business and regulatory issues, and market-access support across India, South America, South East Asia, Middle-East, and Far-East markets. They do not offer discrete software products or technology platforms.
Differentiator
Problem solved
Functional benefit
Products and services
- Late-Stage Clinical Development Investment Equity investment covering 30-60% of funding required for late-stage clinical development (Phase II, III, or IV) for life sciences companies in Pharmaceuticals, BioPharmaceuticals, Medical Devices, Botanicals, Nutraceuticals, and Cosmeceuticals, with particular focus on Orphan Drugs and 505(b)(2) candidates. Returns are realized through portfolio company exits via strategic sales, IPOs, or other liquidity events.
- Regulatory and Clinical Strategy Advisory Mentoring and advisory services provided to portfolio companies on complex business situations, regulatory issues, and clinical/regulatory strategy development, leveraging the team's deep expertise in drug development processes. Provided as part of the partnership relationship with invested companies.
- Emerging Market Access Support Market-access support and assistance with raising additional funds for portfolio companies across emerging markets, specifically India, South America, South East Asia, Middle-East, and Far-East, leveraging BioIdeations' professional network.
Companies that use BioIdeations
Customer profileSegments1 record
Ideal customer profiles1 record
BioIdeations technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioIdeations partnerships and signals
Strategic signalScale indicators3 records
Recent moves3 records
Expansion highlights3 records
BioIdeations competitors and assessment
Company assessmentDirect peers
- RA Capital Management: RA Capital is a Boston-based multi-stage life-sciences investor known for both private and public clinical-development financings. Like BioIdeations, RA takes concentrated positions in Phase II/III assets with deep therapeutic and regulatory diligence as a core capability.
- Flagship Pioneering: Flagship Pioneering is a biotech creation platform that also invests heavily in clinical assets and supports portfolio companies scientifically and operationally. Its deeply embedded operating model parallels BioIdeations' emphasis on active mentorship of portfolio management teams.
- Baker Bros. Advisors: Baker Bros. is a dedicated biotech specialist focused on public and private late-stage therapeutics, with a multi-decade team of scientific and clinical advisors — directly comparable to BioIdeations' deep regulatory and drug-development bench.
- OrbiMed: OrbiMed is a global healthcare-dedicated investment firm spanning private equity, venture, and royalties across all development stages. BioIdeations is comparable because both focus exclusively on life-sciences investing and provide strategic, value-add capital to clinical-stage drug developers.
- Atlas Venture: Atlas Venture builds and funds early-to-mid-stage biotech companies with a "venture creation" approach. The firm's active operating partnership with management teams and clinical-development focus closely mirrors BioIdeations' partnership-style investment model.
- 5AM Ventures: 5AM Ventures is a US early- and mid-stage biotech investor concentrated on platform and clinical-stage therapeutics. The hands-on company-building approach and clinical-development concentration make it a close functional peer to BioIdeations.
- Apposite Capital: Apposite Capital is a UK- and Europe-focused healthcare PE/VC firm investing in clinical and commercial-stage life-sciences businesses. It is comparable to BioIdeations for its clinical-stage focus, geographic breadth, and active operating support to portfolio companies.
- Sofinnova Partners: Sofinnova is a leading European life-sciences venture firm investing across clinical-development stages with strong cross-Atlantic networks. Its clinical-stage focus and cross-border orientation are comparable to BioIdeations' US/Europe/India/SEA reach.
- ARCH Venture Partners: ARCH is a long-tenured US biotech-focused VC investing across formation through late clinical stages. BioIdeations shares ARCH's model of deep scientific underwriting and partnership-style support for clinical-stage therapeutic platforms.
Regional players
- Tata Capital Healthcare Fund: Tata Capital Healthcare is an India-domiciled PE fund focusing on healthcare and life-sciences investments. It is a relevant regional peer given BioIdeations' Gurgaon base and Indian market-access focus on biopharma, medical devices, and nutraceuticals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks7 records
Key highlights6 records
Customer concentration
BioIdeations social profiles
Digital presenceBioIdeations financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioIdeations leadership team
Management profileNumber of profiles
BioIdeations funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioIdeations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioIdeations
What does BioIdeations do?
BioIdeations is a life sciences investment firm that provides equity capital covering 30-60% of late-stage clinical development costs for life sciences companies at Phase II, III, or IV of clinical development, or ready to commercialize. The firm focuses on Pharmaceuticals, BioPharmaceuticals, Medical Devices, Botanicals, Nutraceuticals, and Cosmeceuticals, with particular interest in Orphan Drugs and 505(b)(2) candidates. In addition to capital, BioIdeations provides mentoring on regulatory and business issues, clinical/regulatory strategy development, and market-access support across India, South America, South East Asia, Middle-East, and Far-East.
Is BioIdeations a public or private company?
BioIdeations is a private company. It is classified as unknown and is currently operating.
When was BioIdeations founded?
BioIdeations was founded in -1. It employs 1 to 10 people.
Where is BioIdeations based?
BioIdeations is headquartered in Gurugram, India, in the Asia region.
How does BioIdeations make money?
One revenue line is on record: investment Returns.
Who are BioIdeations's main competitors?
Direct peers on record are RA Capital Management, Flagship Pioneering, Baker Bros. Advisors, OrbiMed, Atlas Venture, 5AM Ventures, Apposite Capital, Sofinnova Partners and ARCH Venture Partners. Tata Capital Healthcare Fund is listed as a regional player.
Does BioIdeations have an API?
No public API is recorded for BioIdeations.
What industry is BioIdeations in?
BioIdeations's product category is Life Sciences Investment. Its primary akta.pro industry code is HLAAAHAJ, Biosimilar Development & Clinical/Regulatory Services (comparability, trials, pharmacovigilance), with a secondary code of EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives. Its NAICS code is 523940 and its SIC code is 6282.